Pegloxenatide is a glucagon-like peptide-1 receptor (GLP-1 RA) agonist. Pegloxenatide can be used for type 2 diabetes research.
References:
[1]. X-Y Li, et al.Effect of polyetlene Glycol Loxenatide (long-acting GLP-1RA) on lipid, glucose levels and weight in type 2 diabetes mellitus patients with obesity. Eur Rev Med Pharmacol Sci. 2022, 26, 21.
[2]. Lei Liu, et al. Long-Term Cost-Effectiveness of Subcutaneous Once-Weekly Semaglutide Versus Polyetlene Glycol Loxenatide for Treatment of Type 2 Diabetes Mellitus in China. Diabetes Ther. 2023, 14, 1.
















